Company / SG&A Expense
Atai Beckley N.V. SG&A Expense History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$47.5M
FY2025
5-year range
$47.5M / $92.7M
FY2021-FY2025
Trend
+0.0%
vs FY2024
Sector context
#165 of 213
Health Care
What the data says
Atai Beckley N.V.'s sg&a expense of $48M is lower than 77% of companies in the Health Care sector (FY2025). Improved from $64M to $48M over the past 2 years.
Based on SEC 10-K filings.
$48M in FY2025 with a 5-year CAGR of -10.0%.
Improved from $64M to $48M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -12.2%
- 5-Year CAGR
- -10.0%
- 10-Year CAGR
- -
Sector benchmark
Top 23% in Health CareTop 23% of 213This company $47.5M Sector average $722.3M
▼
-93.4% below sector average
Key checks
Key Insights
- 5-year CAGR of -10.0%, indicating a declining trend.
- In FY2025, sg&a expense increased 0.0% year-over-year.
- Ranks #165 out of 213 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.84 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $47.5M | +0.0% |
| FY2024 | $47.5M | -25.2% |
| FY2023 | $63.6M | -9.6% |
| FY2022 | $70.3M | -24.1% |
| FY2021 | $92.7M | +14.9% |
| FY2020 | $80.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026